
    
      To evaluate the safety and plasma pharmacokinetics (PK) of clindamycin and adapalene in
      IDP-126 Gel compared with that from Control Gel in subjects with moderate to severe acne
      vulgaris (acne) during once daily topical application of IDP-126 Gel for 28 days.
    
  